Please wait a minute...
 Home  About the Journal Editorial Board Aims & Scope Peer Review Policy Subscription Contact us
 
Early Edition  //  Current Issue  //  Open Special Issues  //  Archives  //  Most Read  //  Most Downloaded  //  Most Cited
Aging and Disease    2015, Vol. 6 Issue (2) : 95-108     DOI: 10.14336/AD.2014.0228
Review Article |
Modelling the p53/p66Shc Aging Pathway in the Shortest Living Vertebrate Nothobranchius Furzeri
Chiara Priami1,3,Giulia De Michele1,Franco Cotelli3,Alessandro Cellerino4,Marco Giorgio1,Pier Giuseppe Pelicci1,2,*(),Enrica Migliaccio1,*()
1European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy.
2Dipartimento di Medicina, Chirurgia e Odontoiatria, University of Milan, Italy
3Dipartimento di Bioscienze, University of Milan, Italy.
4Scuola Normale Superiore, Pisa, Italy
Download: PDF(757 KB)   HTML
Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks    
Abstract  

Oxidative stress induced by reactive oxygen species (ROS) increases during lifespan and is involved in aging processes. The p66Shc adaptor protein is a master regulator of oxidative stress response in mammals. Ablation of p66Shc enhances oxidative stress resistance both in vitro and in vivo. Most importantly, it has been demonstrated that its deletion retards aging in mice. Recently, new insights in the molecular mechanisms involving p66Shc and the p53 tumor suppressor genes were given: a specific p66Shc/p53 transcriptional regulation pathway was uncovered as determinant in oxidative stress response and, likely, in aging. p53, in a p66Shc-dependent manner, negatively downregulates the expression of 200 genes which are involved in the G2/M transition of mitotic cell cycle and are downregulated during physiological aging. p66Shc modulates the response of p53 by activating a p53 isoform (p44/p53, also named Delta40p53). Based on these latest results, several developments are expected in the future, as the generation of animal models to study aging and the evaluation of the use of the p53/p66Shc target genes as biomarkers in aging related diseases. The aim of this review is to investigate the conservation of the p66Shc and p53 role in oxidative stress between fish and mammals. We propose to approach this study trough a new model organism, the annual fish Nothobranchius furzeri, that has been demonstrated to develop typical signs of aging, like in mammals, including senescence, neurodegeneration, metabolic disorders and cancer.

Keywords stress response      p53      cell cycle checkpoint G2/M      senescence      aging      nothobranchius furzeri      animal models     
Corresponding Authors: Pier Giuseppe Pelicci,Enrica Migliaccio     E-mail: piergiuseppe.pelicci@ieo.eu;enrica.migliaccio@ieo.eu
Just Accepted Date: 13 February 2015   Online First Date: 23 November 2014    Issue Date: 25 March 2015
Service
E-mail this article
E-mail Alert
RSS
Articles by authors
Chiara Priami
Giulia De Michele
Franco Cotelli
Alessandro Cellerino
Marco Giorgio
Pier Giuseppe Pelicci
Enrica Migliaccio
Cite this article:   
Chiara Priami,Giulia De Michele,Franco Cotelli, et al. Modelling the p53/p66Shc Aging Pathway in the Shortest Living Vertebrate Nothobranchius Furzeri[J]. A&D, 2015, 6(2): 95-108.
URL:  
http://www.aginganddisease.org/EN/10.14336/AD.2014.0228     OR     http://www.aginganddisease.org/EN/Y2015/V6/I2/95
Figure 1.  Multiple sequence alignment of p53 of different species. Predicted p53 orthologs were searched using online resources (UCSC Genome Browser, Ensembl Genome Browser and Nothobranchius furzeri transcriptome browser found at https://gen100.imb-jena.de/EST2UNI/nfintb/) and aligned using the online Praline program. Post-translational modified amino acid residues conserved in 7 or more out of 9 species are boxed in black and highlighted with a black spot: note that S15, the phosphorylation site of ATM, is conserved in all the species with the exception of N. furzeri; post-translational modified amino acid residues conserved in 6 or 5 out of 9 species are boxed in red; post-translational modified amino acid residues conserved in 3 or 4 out of 9 are boxed in orange or blue; post-translational modified amino acid residues conserved in 2 out of 9 species are boxed in yellow; post-translational modified amino acid residues present only in human sequence are not indicated. Starting site of Transactivating Domain (TAD), Proline rich Domain (PRD), DNA Binding Domain (DBD), Tetramerization Domain (TD) and C-terminal Regulating Domain (CRD) are indicated. Hsa: Homo sapiens, Mmu: Mus musculus, Xtr: Xenopus tropicalis, Ola: Oryzias latipes (medaka), Tru: Takifugu rubripes (fugu), Dre: Danio rerio (zebrafish), Nfu: Nothobranchius furzeri, Dme: Drosophila melanogaster, Cel: Caenorhabditis elegans.
Figure 2.  Modular organization of p53 orthologs of different vertebrate and invertebrate species. TAD, violet: Transactivation Domain; PRD, green: Proline Rich Domain; DBD, yellow: DNA Binding Domain, TD, dark blue: Tetramerization domain; CRD, fuchsia: C-terminal Regulatory Domain. Post-translational modified amino acid residues are indicated: serines with a pink spot, threonines with a blue spot, and lysines with a green spot and cysteines with an orange spot. For Homo sapiens, it is also indicated the position in the sequence and the type of post-translational modification (P=phosphorylation, A=acetylation, R=changing of the redox status, G=glycosylation, N=neddylation, S=sumoylation, M=methylation and U=ubiquitination). Amino acids of the human sequence are also numbered from 1 to 43: in other sequences than human, conserved amino acid residues are indicated only with the corresponding number and not with the position in their sequence. Amino acids are considered conserved even if they are substituted with a functionally similar one: for example, T18 is not found in N. furzeri, but this amino acid is here substituted with a serine, thus the number (4) is the same, but the color of the spot changes from blue to pink. S15 is indicated with a pink spot surrounded by a black circle: we want to focus the attention on this residue because it is the best known target site of ATM (Ataxia-Telangiectasia Mutated) kinase and it is one of the few amino acids conserved among all the considered species, with the interesting exception of N. furzeri.
Figure 3.  Multiple sequence alignment of p66Shc CH2 domain of different species. Predicted p66Shc orthologs were searched using online resources (UCSC Genome Browser, Ensembl Genome Browser and Nothobranchius furzeri transcriptome browser found at https://gen100.imb-jena.de/EST2UNI/nfintb/) and aligned using the online Praline program. High homology regions within the CH2 domains are boxed in blue. Post-translational modified amino acid residues conserved in 8 or more out of 10 sequences are boxed in black and highlighted with a black spot: S54 is conserved among vertebrates and C. elegans T27F7.2; S139 is conserved among vertebrates and Drosophila. Post-translational modified amino acid residues conserved in 7 out of 10 sequences are boxed in red and highlighted with a red spot: S36 is conserved in vertebrates (with the exception of D. rerio) and C. elegans T27F7.2; amino acids constituting the Cytochrome c binding domain (E125, E132, E133, W134 and W148) of p66Shc are conserved in vertebrates. Starting methionine of the predicted p66Shc is boxed in orange. Starting methionine of the predicted p52Shc is boxed in black: it is strictly conserved among vertebrates. Starting methionine of the predicted p46Shc is boxed in blue: it is conserved in mammals, X. tropicalis, D. melanogaster and C. elegans T27F7.2. Starting site of Phosphotyrosine Binding Domain (PTB) is indicated. Hsa: Homo sapiens, Mmu: Mus musculus, Xtr: Xenopus tropicalis, Ola: Oryzias latipes (medaka), Tru: Takifugu rubripes (fugu), Dre: Danio rerio (zebrafish), Nfu: Nothobranchius furzeri, Dme: Drosophila melanogaster, Cel: Caenorhabditis elegans T27F7.2 and F54A5.3a.
Figure 4.  Modular organization of p66Shc orthologs of different vertebrate species. CH2, light green: Collagen Homology 2 domain; PTB, red: Phosphotyrosine Binding Domain; CH1, light blue: Collagen Homology 1 domain; SH2, yellow: Src homology 2 domain. Note that a CH2 region is present in all the vertebrate species, whereas it is absent or not recognizable in invertebrates. Post-translational modified amino acid residues are indicated: serines with a pink spot, threonines with a blue spot and tyrosines with a light green spot. For Homo sapiens, it is also indicated the position in the sequence and the type of post-translational modification (P=phosphorylation). Amino acids of the human sequence are also numbered from 1 to 7: in other sequences than human, conserved amino acid residues are indicated only with the corresponding number and not with the position in their sequence. Amino acids are considered conserved even if they are substituted with a functionally similar one: T386 is not found in X. tropicalis, but this amino acid is here substituted with a serine, thus the number (6) is the same, but the color of the spot changes from blue to pink. The Cytochrome c Binding (CB) domain is indicated with a yellow pentagon with the amino acids of the core: EEW in H. sapiens and M. musculus, DEW in X. tropicalis, N. furzeri and D. rerio. Starting site of the p52Shc isoform is also indicated with an arrow.
[1] Holzenberger M,Dupont J,Ducos B,Leneuve P,Geloen A,Even PC,Cervera P,Le Bouc Y (2003). IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice. Nature, 421: 182–187
http://dx.doi.org/10.1038/nature01298
[2] Bartke A,Brown-Borg H (2004). Life extension in the dwarf mouse. Curr Top Dev Biol, 63:189–225
http://dx.doi.org/10.1016/S0070-2153(04)63006-7
[3] Yamamoto M,Clark JD,Pastor JV,Gurnani P,Nandi A,Kurosu H,Miyoshi M,Ogawa Y,Castrillon DH,Rosenblatt KP andKuro-o M (2005). Regulation of oxidative stress by the anti-aging hormone klotho. J Biol Chem, 280: 38029–38034
http://dx.doi.org/10.1074/jbc.M509039200
[4] Migliaccio E,Giorgio M,Mele S,Pelicci G,Reboldi P,Pandolfi PP,Lanfrancone L,Pelicci PG (1999). The p66shc adaptor protein controls oxidative stress response and life span in mammals. Nature, 402:309–313
http://dx.doi.org/10.1038/46311
[5] Carpi A,Menabo R,Kaludercic N,Pelicci P,Di Lisa F,Giorgio M (2009). The cardioprotective effects elicited by p66(Shc) ablation demonstrate the crucial role of mitochondrial ROS formation in ischemia/reperfusion injury. Biochim Biophys Acta, 1787:774–780
http://dx.doi.org/10.1016/j.bbabio.2009.04.001
[6] Fadini GP,Albiero M,Menegazzo L,Boscaro E,Pagnin E,Iori E,Cosma C,Lapolla A,Pengo V,Stendardo M,Agostini C,Pelicci PG,Giorgio M,Avogaro A (2010). The redox enzyme p66Shc contributes to diabetes and ischemia-induced delay in cutaneous wound healing. Diabetes, 59:2306–2314
http://dx.doi.org/10.2337/db09-1727
[7] Savino C,Pelicci P,Giorgio M (2013). The P66Shc/mitochondrial permeability transition pore pathway determines neurodegeneration. Oxid Med Cell Longev, 2013:719407.
[8] Harman D (1981). The aging process. Proc Natl Acad Sci USA, 78:7124–7128
http://dx.doi.org/10.1073/pnas.78.11.7124
[9] Kujoth GC,Hiona A,Pugh TD, et al (2005). Mitochondrial DNA mutations, oxidative stress and apoptosis in mammalian aging. Science, 309: 481–484
http://dx.doi.org/10.1126/science.1112125
[10] Naylor RM,Baker DJ,van Deursen JM (2013). Senescent cells: a novel therapeutic target for aging and age-related diseases. Clin Pharmacol Ther, 93:105–116
http://dx.doi.org/10.1038/clpt.2012.193
[11] Pelicci G,Lanfrancone L,Grignani F, et al (1992). A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction. Cell, 70: 93–104
http://dx.doi.org/10.1016/0092-8674(92)90536-L
[12] Bonfini L,Migliaccio E,Pelicci G,Lanfrancone L,Pelicci PG (1996). Not all Shc’s roads lead to Ras. Trends Biochem Sci, 21:257–261
http://dx.doi.org/10.1016/S0968-0004(96)10033-5
[13] Migliaccio E,Mele S,Salcini AE, et al (1997).Opposite effects of the p52shc/p46shc and p66shc splicing isoforms on the EGF receptor-MAP kinase-fos signalling pathway. EMBO J, 16:706–716
http://dx.doi.org/10.1093/emboj/16.4.706
[14] Luzi L,Confalonieri S,Di Fiore PP,Pelicci PG (2000).Evolution of Shc functions from nematode to human. Curr Opin Genet Dev, 10:668–674
http://dx.doi.org/10.1016/S0959-437X(00)00146-5
[15] Trinei M,Giorgio M,Cicalese A, et al (2002). A p53-p66Shc signalling pathway controls intracellular redox status, levels of oxidation-damaged DNA and oxidative stress-induced apoptosis. Oncogene, 21:3872–3878
http://dx.doi.org/10.1038/sj.onc.1205513
[16] Migliaccio E,Giorgio M,Pelicci PG (2006). Apoptosis and aging: role of p66Shc redox protein. Antioxid Redox Signal, 8:600–608
http://dx.doi.org/10.1089/ars.2006.8.600
[17] Trinei M,Berniakovich I,Beltrami E,Migliaccio E,Fassina A,Pelicci P,Giorgio M (2009). P66Shc signals to age. Aging, 1(6): 503–510
[18] Ramsey JJ,Tran D,Giorgio M, et al (2013). The Influence of Shc Proteins on Life Span in Mice. J Gerontol A Biol Sci Med Sci, in press.
[19] Orsini F,Migliaccio E,Moroni M, et al (2004). The life span determinant p66Shc localizes to mitochondria where it associates with mitochondrial heat shock protein 70 and regulates trans-membrane potential. J Biol Chem, 279:25689–25695
http://dx.doi.org/10.1074/jbc.M401844200
[20] Giorgio M,Migliaccio E,Orsini F, et al (2005). Electron transfer between cytochrome c and p66Shc generates reactive oxygen species that trigger mitochondrial apoptosis. Cell, 122:221–233
http://dx.doi.org/10.1016/j.cell.2005.05.011
[21] Feng Z,Lin M,Wu R (2011). The Regulation of Aging and Longevity: A New and Complex Role of p53. Genes Cancer, 2:443–452
http://dx.doi.org/10.1177/1947601911410223
[22] Maier B,Gluba W,Bernier B, et al (2004). Modulation of mammalian life span by the short isoform of p53. Genes Dev, 18:306–319
http://dx.doi.org/10.1101/gad.1162404
[23] Gambino V,De Michele G,Venezia O, et al (2013). Oxidative stress activates a specific p53 transcriptional-response that regulates cellular senescence and aging. Aging Cell, 12:435–45.
http://118.145.16.217/magsci/article/article?id=19266301
[24] Di Cicco E,Tozzini ET,Rossi G,Cellerino A (2011). The short-lived annual fish Nothobranchius furzeri shows a typical teleost aging process reinforced by high incidence of age-dependent neoplasias. Exp Gerontol, 46:249–256
http://118.145.16.217/magsci/article/article?id=15012300
[25] Valdesalici S,Cellerino A (2003). Extremely short lifespan in the annual fish Nothobranchius furzeri. Proc Biol Sci, 270 (Suppl 2S): 189–191
http://dx.doi.org/10.1098/rspb.2002.2233
[26] Kenyon C (1996). Ponce d’elegans: genetic quest for the fountain of youth. Cell, 84:501–504
http://dx.doi.org/10.1016/S0092-8674(00)81024-7
[27] Guarente L,Kenyon C (2000). Genetic pathways that regulate ageing in model organisms. Nature, 408:255–262
http://dx.doi.org/10.1038/35041700
[28] Ladiges W,Van Remmen H,Strong R,Ikeno Y,Treuting P,Rabinovitch P,Richardson A (2009). Lifespan extension in genetically modified mice. Aging Cell, 8:346–352
http://dx.doi.org/10.1111/j.1474-9726.2009.00491.x
[29] Dorn A,Ng’oma E,Janko K,Reichwald K,Polacik M,Platzer M,Cellerino A,Reichard M (2011). Phylogeny, genetic variability and colour polymorphism of an emerging animal model: the short-lived annual Nothobranchius fishes from southern Mozambique. Mol Phylogenet Evol, 61:739–749
http://dx.doi.org/10.1016/j.ympev.2011.06.010
[30] Terzibasi E,Valenzano DR,Benedetti M,Roncaglia P,Cattaneo A,Domenici L,Cellerino A (2008). Large differences in aging phenotype between strains of the short-lived annual fish Nothobranchius furzeri. PLoS One, 3:e3866
http://dx.doi.org/10.1371/journal.pone.0003866
[31] Genade T,Benedetti M,Terzibasi E, et al (2005). Annual fishes of the genus Nothobranchius as a model system for aging research. Aging Cell, 4:223–233
http://dx.doi.org/10.1111/j.1474-9726.2005.00165.x
[32] Valenzano DR,Terzibasi E,Genade T, et al (2006). Resveratrol prolongs lifespan and retards the onset of age-related markers in a short-lived vertebrate. Curr Biol, 16:296–300
http://118.145.16.217/magsci/article/article?id=14161407
[33] Kirschner J,Weber D,Neuschl C, et al (2012). Mapping of quantitative trait loci controlling lifespan in the short-lived fish Nothobranchius furzeri--a new vertebrate model for age research. Aging Cell, 11:252–61.
http://dx.doi.org/10.1111/j.1474-9726.2011.00780.x
[34] Baumgart M,Groth M,Priebe S, et al (2012) Age-dependent regulation of tumor-related microRNAs in the brain of the annual fish Nothobranchius furzeri . Mech Ageing Dev, 133:226–33.
http://dx.doi.org/10.1016/j.mad.2012.03.015
[35] Petzold A,Reichwald K,Groth M, et al (2013). The transcript catalogue of the short-lived fish Nothobranchius furzeri provides insights into age-dependent changes of mRNA levels. BMC Genomics, 14: 185–201
http://dx.doi.org/10.1186/1471-2164-14-185
[36] Li IC,Chan CT,Lu YF, (2011) Zebrafish kruppel-like factor 4a represses intestinal cell proliferation and promotes differentiation of intestinal cell lineages. PLoS One, 6:e20974.
http://dx.doi.org/10.1371/journal.pone.0020974
[37] Donnini S,Giachetti A,Ziche M (2013) Assessing vascular senescence in zebrafish. Methods Mol Biol, 965:517–31.
http://dx.doi.org/10.1007/978-1-62703-239-1_34
[38] Santoriello C,Deflorian G,Pezzimenti F, et al (2009) Expression of H-RASV12 in a zebrafish model of Costello syndrome causes cellular senescence in adult proliferating cells. Dis Model Mech, 2:56–67.
http://dx.doi.org/10.1242/dmm.001016
[39] Anchelin M,Alcaraz-Pérez F,Martínez CM, et al (2013) Premature aging in telomerase-deficient zebrafish. Dis Model Mech. 6:1101–12.
http://dx.doi.org/10.1242/dmm.011635
[40] Maier B,Gluba W,Bernier B, et al (2004). Modulation of mammalian life span by the short isoform of p53. Genes Dev, 18:306–319
http://dx.doi.org/10.1101/gad.1162404
[41] Tyner SD,Venkatachalam S,Choi J, et al (2002). p53 mutant mice that display early ageing-associated phenotypes. Nature, 415:45–53
http://dx.doi.org/10.1038/415045a
[42] Garcia-Cao I,Garcia-Cao M,Martin-Caballero J, et al (2002). "Super p53" mice exhibit enhanced DNA damage response, are tumor resistant and age normally. EMBO J, 21:6225–6235
http://dx.doi.org/10.1093/emboj/cdf595
[43] Belyi VA,Ak P,Markert E, et al (2010). The origins and evolution of the p53 family of genes. Cold Spring Harb Perspect Biol, 2: a001198
[44] Jeon HY andLee H (2013). Depletion of Aurora-A in zebrafish causes growth retardation due to mitotic delay and p53-dependent cell death. FEBS J, 280: 1518–1530
http://118.145.16.217/magsci/article/article?id=19858722
[45] Gunther EJ,Moody SE,Belka GK, et al (2003). Impact of p53 loss on reversal and recurrence of conditional Wnt-induced tumorigenesis. Genes Dev, 17: 488–501
http://dx.doi.org/10.1101/gad.1051603
[46] Le Bras M,Bensaad K,Soussi T (2003). Data mining the p53 pathway in the Fugu genome: evidence for strong conservation of the apoptotic pathway. Oncogene, 22:5082–5090
http://dx.doi.org/10.1038/sj.onc.1206424
[47] Yasuda T,Oda S,Li Z,Kimori Y,Kamei Y,Ishikawa T,Todo T,Mitani H (2012). Gamma-ray irradiation promotes premature meiosis of spontaneously differentiating testis-ova in the testis of p53-deficient medaka (Oryzias latipes). Cell Death Dis, 3e395
[48] Dai C,Gu W (2010). p53 post-translational modification: deregulated in tumorigenesis. Trends Mol Med, 16:528–536
http://118.145.16.217/magsci/article/article?id=15424859
[49] Iwakuma T,Lozano G (2007). Crippling p53 activities via knock-in mutations in mouse models. Oncogene, 26; 2177–2184.
http://dx.doi.org/10.1038/sj.onc.1210278
[50] Tang Y,Luo J,Zhang W,Gu W (2006). Tip60-dependent acetylation of p53 modulates the decision between cell-cycle arrest and apoptosis. Mol Cell, 24:827–839
http://dx.doi.org/10.1016/j.molcel.2006.11.021
[51] Chao C,Herr D,Chun J,Xu Y (2006). Ser18 and 23 phosphorylation is required for p53-dependent apoptosis and tumor suppression. EMBO J, 25:2615–2622
[52] Tang Y,Zhao W,Chen Y,Zhao Y,Gu W (2008). Acetylation is indispensable for p53 activation. Cell, 133: 612–626.
http://dx.doi.org/10.1016/j.cell.2008.03.025
[53] Rainwater R,Parks D,Anderson ME,Tegtmeyer P,Mann K (1995). Role of cysteine residues in regulation of p53 function. Mol Cell Biol, 15:3892–3903
[54] Stoner CS,Pearson GD,Koc A,Merwin JR,Lopez NI,Merrill GF (2009). Effect of thioredoxin deletion and p53 cysteine replacement on human p53 activity in wild-type and thioredoxin reductase null yeast. Biochemistry, 48: 9156–9169
http://dx.doi.org/10.1021/bi900757q
[55] Gully CP,Velazquez-Torres G,Shin JH, et al (2012). Aurora B kinase phosphorylates and instigates degradation of p53. Proc Natl Acad Sci U S A, 109:E1513–1522
http://dx.doi.org/10.1073/pnas.1110287109
[56] Liu Q,Kaneko S,Yang L, et al (2004). Aurora-A abrogation of p53 DNA binding and transactivation activity by phosphorylation of serine 215. J Biol Chem, 279: 52175–52182
http://dx.doi.org/10.1074/jbc.M406802200
[57] Matsumoto M,Furihata M,Ohtsuki Y (2006) Posttranslational phosphorylation of mutant p53 protein in tumor development. Med Mol Morphol, 39:79–87
http://118.145.16.217/magsci/article/article?id=15596022
[58] Wang YH,Tsay YG,Tan BC,Lo WY,Lee SC (2003) Identification and characterization of a novel p300-mediated p53 acetylation site, lysine 305. J Biol Chem, 278:25568–25576
http://dx.doi.org/10.1074/jbc.M212574200
[59] Kruse JP,Gu W (2008). SnapShot: p53 posttranslational modifications. Cell, 133, 930–930 e931.
http://dx.doi.org/10.1016/j.cell.2008.05.020
[60] Lanfrancone L,Pelicci G,Brizzi MF, et al (1995). Overexpression of Shc proteins potentiates the proliferative response to the granulocyte-macrophage colony-stimulating factor and recruitment of Grb2/SoS and Grb2/p140 complexes to the beta receptor subunit. Oncogene, 10:907–917
[61] Berniakovich I,Trinei M,Stendardo M, et al (2008). p66Shc-generated oxidative signal promotes fat accumulation. J Biol Chem, 283:34283–34293
http://dx.doi.org/10.1074/jbc.M804362200
[62] Ranieri SC,Fusco S,Panieri E, et al (2010). Mammalian life-span determinant p66shcA mediates obesity-induced insulin resistance. Proc Natl Acad Sci U S A, 107:13420–13425
http://dx.doi.org/10.1073/pnas.1008647107
[63] Menini S,Amadio L,Oddi G, et al (2006). Deletion of p66Shc longevity gene protects against experimental diabetic glomerulopathy by preventing diabetes-induced oxidative stress. Diabetes, 55: 1642–1650
http://dx.doi.org/10.2337/db05-1477
[64] Fadini GP,Albiero M,Menegazzo L, et al (2010). The redox enzyme p66Shc contributes to diabetes and ischemia-induced delay in cutaneous wound healing. Diabetes, 59: 2306–2314
http://dx.doi.org/10.2337/db09-1727
[65] Napoli C,Martin-Padura I,de Nigris F, et al (2003). Deletion of the p66Shc longevity gene reduces systemic and tissue oxidative stress, vascular cell apoptosis, and early atherogenesis in mice fed a high fat diet. Proc Natl Acad Sci U S A, 100:2112–2116
http://dx.doi.org/10.1073/pnas.0336359100
[66] Graiani G,Lagrasta C,Migliaccio E, et al (2005). Genetic deletion of the p66Shc adaptor protein protects from angiotensin II-induced myocardial damage. Hypertension, 46:433–440
http://dx.doi.org/10.1161/01.HYP.0000174986.73346.ba
[67] Zaccagnini G,Martelli F,Fasanaro P, et al (2004). p66ShcA modulates tissue response to hindlimb ischemia. Circulation, 109: 2917–2923
http://dx.doi.org/10.1161/01.CIR.0000129309.58874.0F
[68] Carpi A,Menabo R,Kaludercic N, et al (2009). The cardioprotective effects elicited by p66 (Shc) ablation demonstrate the crucial role of mitochondrial ROS formation in ischemia/reperfusion injury. Biochim Biophys Acta, 1787: 774–780
http://dx.doi.org/10.1016/j.bbabio.2009.04.001
[69] Cattaneo E,Pelicci PG (1998). Emerging roles for SH2/PTB-containing Shc adaptor proteins in the developing mammalian brain. Trends Neurosci, 21:476–481
http://dx.doi.org/10.1016/S0166-2236(98)01282-X
[70] Kojima T,Yoshikawa Y,Takada S, et al (2001). Genomic organization of the Shc-related phosphotyrosine adapters and characterization of the full-length Sck/ShcB: specific association of p68-Sck/ShcB with pp135. Biochem Biophys Res Commun, 284:1039–1047
http://dx.doi.org/10.1006/bbrc.2001.5080
[71] Fagiani E,Giardina G,Luzi L, et al (2007). RaLP, a new member of the Src homology and collagen family, regulates cell migration and tumor growth of metastatic melanomas. Cancer Res, 67:3064–3073
http://dx.doi.org/10.1158/0008-5472.CAN-06-2301
[72] Aoto M,Sato K,Takeba S, et al (1999). “A 58-kDa Shc protein is present in Xenopus eggs and is phosphorylated on tyrosine residues upon egg activation.”. Biochem Biophys Res Commun, 258:265–70.
http://dx.doi.org/10.1006/bbrc.1999.0624
[73] Sato K,Ogawa K,Tokmakov AA,Iwasaki T,Fukami Y (2001). Hydrogen peroxide induces Src family tyrosine kinase-dependent activation of Xenopus eggs. Dev Growth Differ, 43:55–72
http://dx.doi.org/10.1046/j.1440-169x.2001.00554.x
[74] Chesnel F,Heligon C,Richard-Parpaillon L,Boujard D (2003). Molecular cloning and characterization of an adaptor protein Shc isoform from Xenopus laevis oocytes. Biol Cell, 95:311–320
http://dx.doi.org/10.1016/S0248-4900(03)00058-3
[75] Yamaguchi F,Yamaguchi K,Tokuda M,Brenner S (1999). Molecular cloning of EDG-3 and N-Shc genes from the puffer fish, Fugu rubripes, and conservation of synteny with the human genome. FEBS Lett, 459:105–110
http://dx.doi.org/10.1016/S0014-5793(99)01210-7
[76] Sweet DT,Chen Z,Wiley DM,Bautch VL,Tzima E (2011). The adaptor protein Shc integrates growth factor and ECM signaling during postnatal angiogenesis. Blood, 119: 1946–1955
[77] Pinton P,Rimessi A,Marchi S, et al (2007). Protein kinase C beta and prolyl isomerase 1 regulates mitochondrial effects of the life-span determinant p66Shc. Science, 315: 659–663
http://dx.doi.org/10.1126/science.1135380
[78] Foschi M,Franchi F,Han J,La Villa G,Sorokin A (2001). Endothelin-1 induces serine phosphorylation of the adaptor protein p66Shc and its association with 14-3-3 protein in glomerular mesangial cells. J Biol Chem, 276:26640–26647
http://dx.doi.org/10.1074/jbc.M102008200
[79] Kyriakis JM,Avruch J (1996). Sounding the alarm: protein kinase cascades activated by stress and inflammation. J Biol Chem, 4:24313–6.
[80] Karandikar M,Cobb MH (1999) Scaffolding and protein interactions in MAP kinase modules.”. Cell Calcium, 26:219–26
http://dx.doi.org/10.1054/ceca.1999.0074
[81] Hu Y,Wang X,Zeng L,Cai DY,Sabapathy K,Goff SP,Firpo EJ,Li B (2005). ERK phosphorylates p66shcA on Ser36 and subsequently regulates p27kip1 expression via the Akt-FOXO3a pathway: implication of p27kip1 in cell response to oxidative stress. Mol Biol Cell, 16:3705–18.
http://dx.doi.org/10.1091/mbc.E05-04-0301
[82] Le S,Connors TJ,Maroney AC (2001). c-Jun N-terminal kinase specifically phosphorylates p66ShcA at serine 36 in response to ultraviolet irradiation. J Biol Chem, 276:48332–6.
[83] Zhen Y,Hoganson CW,Babcock GT,Ferguson-Miller S (1999). Definition of the interaction domain for cytochrome c on cytochrome c oxidase. I. Biochemical, spectral, and kinetic characterization of surface mutants in subunit ii of Rhodobacter sphaeroides cytochrome aa. J Biol Chem, 274:38032–38041
http://dx.doi.org/10.1074/jbc.274.53.38032
[84] Trinei M,Migliaccio E,Bernardi P,Paolucci F,Pelicci P,Giorgio M (2013). p66Shc, mitochondria, and the generation of reactive oxygen species. Methods Enzymol, 528: 99–11
http://dx.doi.org/10.1016/B978-0-12-405881-1.00006-9
[85] Gertz M,Fischer F,Wolters D,Steegborn C (2008). Activation of the lifespan regulator p66Shc through reversible disulfide bond formation. Proc Natl Acad Sci U S A., 105: 5705–9.
http://dx.doi.org/10.1073/pnas.0800691105
[86] Faisal A,el-Shemerly M,Hess D,Nagamine Y (2002). Serine/threonine phosphorylation of ShcA. Regulation of protein-tyrosine phosphatase-pest binding and involvement in insulin signaling. J Biol Chem, 277:30144–30152
http://dx.doi.org/10.1074/jbc.M203229200
[87] Khanday FA,Yamamori T,Mattagajasingh I, et al (2006). Rac1 leads to phosphorylation-dependent increase in stability of the p66shc adaptor protein: role in Rac1-induced oxidative stress. Mol Biol Cell, 17:122–129
[88] Salcini AE,McGlade J,Pelicci G, et al (1994). Formation of Shc-Grb2 complexes is necessary to induce neoplastic transformation by overexpression of Shc proteins. Oncogene, 9:2827–2836
[89] Gotoh T,Niino Y,Tokuda M,Hatase O,Nakamura S,Matsuda M,Hattori S (1997). Activation of R-Ras by Ras-guanine nucleotide-releasing factor. J Biol Chem, 272:18602–18607
http://dx.doi.org/10.1074/jbc.272.30.18602
[90] Aylon Y,Oren M (2007). Living with p53, dying of p53. Cell, 130:597–600.
http://dx.doi.org/10.1016/j.cell.2007.08.005
[91] Olivares-Illana V,Fahraeus R (2010). p53 isoforms gain functions. Oncogene, 29:5113–5119
http://dx.doi.org/10.1038/onc.2010.266
[92] Marcel V,Dichtel-Danjoy ML,Sagne C, et al (2011). Biological functions of p53 isoforms through evolution: lessons from animal and cellular models. Cell Death Differ, 18:1815–1824
http://dx.doi.org/10.1038/cdd.2011.120
[93] Bourougaa K,Naski N,Boularan C, et al (2012). Endoplasmic reticulum stress induces G2 cell-cycle arrest via mRNA translation of the p53 isoform p53/47. Mol Cell, 38:78–88
[94] Davidson WR,Kari C,Ren Q, et al (2010). Differential regulation of p53 function by the N-terminal DeltaNp53 and Delta113p53 isoforms in zebrafish embryos. BMC Dev Biol, 10:102–113
http://dx.doi.org/10.1186/1471-213X-10-102
[95] Bauer JH,Poon PC,Glatt-Deeley H,Abrams JM,Helfand SL (2005). Neuronal expression of p53 dominant-negative proteins in adult Drosophila melanogaster extends life span. Curr Biol, 15:2063–2068
http://dx.doi.org/10.1016/j.cub.2005.10.051
[96] Ventura N,Rea SL,Schiavi A,Torgovnick A,Testi R,Johnson TE (2009). p53/CEP-1 increases or decreases lifespan, depending on level of mitochondrial bioenergetic stress. Aging Cell, 8:380–393
http://dx.doi.org/10.1111/j.1474-9726.2009.00482.x
[1] Francesca Bonomini,Luigi Fabrizio Rodella,Rita Rezzani. Metabolic Syndrome, Aging and Involvement of Oxidative Stress[J]. A&D, 2015, 6(2): 109-120.
[2] Stambler Ilia. Stop Aging Disease! ICAD 2014[J]. A&D, 2015, 6(2): 76-94.
[3] Alexandra Moura,José Madureira,Pablo Alija,João Carlos Fernandes,José Gerardo Oliveira,Martin Lopez,Madalena Filgueiras,Leonilde Amado,Maria Sameiro-Faria,Vasco Miranda,Alice Santos-Silva,Elísio Costa. Effect of Aging in the Perception of Health-Related Quality of Life in End-Stage Renal Disease Patients under Online-Hemodiafiltration[J]. Aging and Disease, 2015, 6(1): 17-26.
[4] Amanda Piano,Vladimir I. Titorenko. The Intricate Interplay between Mechanisms Underlying Aging and Cancer[J]. Aging and Disease, 2015, 6(1): 56-75.
[5] Kunlin Jin,James W. Simpkins,Xunming Ji,Miriam Leis,Ilia Stambler. The Critical Need to Promote Research of Aging and Aging-related Diseases to Improve Health and Longevity of the Elderly Population[J]. Aging and Disease, 2015, 6(1): 1-5.
[6] Shinichi Iwasaki,Tatsuya Yamasoba. Dizziness and Imbalance in the Elderly: Age-related Decline in the Vestibular System[J]. Aging and Disease, 2015, 6(1): 38-47.
[7] Baugé Catherine,Girard Nicolas,Lhuissier Eva,Bazille Celine,Boumediene Karim. Regulation and Role of TGFβ Signaling Pathway in Aging and Osteoarthritis Joints[J]. Aging and Disease, 2014, 5(6): 394-405.
[8] Juliane Schulze,Antje Vogelgesang,Alexander Dressel. Catecholamines, Steroids and Immune Alterations in Ischemic Stroke and Other Acute Diseases[J]. Aging and Disease, 2014, 5(5): 327-339.
[9] David Blokh,Ilia Stambler. Estimation of Heterogeneity in Diagnostic Parameters of Age-related Diseases[J]. Aging and Disease, 2014, 5(4): 218-225.
[10] Olaoluwa O Okusaga. Accelerated Aging in Schizophrenia Patients: The Potential Role of Oxidative Stress[J]. Aging and Disease, 2014, 5(4): 256-262.
[11] Shaohua Xu,Ying Cai,Yuehua Wei. mTOR Signaling from Cellular Senescence to Organismal Aging[J]. Aging and Disease, 2014, 5(4): 263-273.
[12] Alejandro Lucas-Sánchez,Pedro Francisco Almaida-Pagán,Pilar Mendiola,Jorge de Costa. Nothobranchius as a model for aging studies. A review[J]. Aging and Disease, 2014, 5(4): 281-291.
[13] Chandan Prasad,Victorine Imrhan,Francesco Marotta,Shanil Juma,Parakat Vijayagopal. Lifestyle and Advanced Glycation End Products (AGEs) Burden: Its Relevance to Healthy Aging[J]. Aging and Disease, 2014, 5(3): 212-217.
[14] Ninu Poulose,Raghavan Raju. Aging and Injury: Alterations in Cellular Energetics and Organ Function[J]. Aging and Disease, 2014, 5(2): 101-108.
[15] Peter M Nilsson. Hemodynamic Aging as the Consequence of Structural Changes Associated with Early Vascular Aging (EVA)[J]. Aging and Disease, 2014, 5(2): 109-113.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
Copyright © 2014 Aging and Disease, All Rights Reserved.
Address: Aging and Disease Editorial Office 3400 Camp Bowie Boulevard Fort Worth, TX76106 USA
Fax: (817) 735-0408 E-mail: editorial@aginganddisease.org
Powered by Beijing Magtech Co. Ltd